Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 10, 2014 - Issue 1
832
Views
20
CrossRef citations to date
0
Altmetric
CLINCAL FORUM

Opiate Dependence in Schizophrenia: Case Presentation and Literature Review

, &
Pages 52-57 | Received 05 Sep 2013, Accepted 13 Nov 2013, Published online: 14 Feb 2014

REFERENCES

  • Barnett , P. G. , Rodgers , J. H. and Bloch , D. A. 2001 . A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence . Addiction , 96 ( 5 ) : 683 – 690 . doi: 10.1046/j.1360-0443.2001.9656834.x
  • Boscarino , J. A. , Rukstalis , M. , Hoffman , S. N. , Han , J. J. , Erlich , P. M. , Gerhard , G. S. and Stewart , W. F. 2010 . Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system . Addiction (Abingdon, England) , 105 ( 10 ) : 1776 – 1782 . doi: 10.1111/j.1360-0443.2010.03052.x
  • Brizer , D. A. , Hartman , N. , Sweeney , J. and Millman , R. B. 1985 . Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia . The American Journal of Psychiatry , 142 ( 9 ) : 1106 – 1107 .
  • Bruchas , M. R. , Land , B. B. and Chavkin , C. 2010 . The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors . Brain Research , 1314 : 44 – 55 . doi: 10.1016/j.brainres.2009.08.062
  • Dani , J. A. and Harris , R. A. 2005 . Nicotine addiction and comorbidity with alcohol abuse and mental illness . Nature Neuroscience , 8 ( 11 ) : 1465 – 1470 . doi: 10.1038/nn1580
  • Drake , R. E. , O’Neal , E. L. and Wallach , M. A. 2008 . A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders . Journal of Substance Abuse Treatment , 34 ( 1 ) : 123 – 138 . doi: 10.1016/j.jsat.2007.01.011
  • Drake , R. E. and Wallach , M. A. 1989 . Substance abuse among the chronic mentally ill . Hospital & Community Psychiatry , 40 ( 10 ) : 1041 – 1046 .
  • Fischer , G. , Gombas , W. , Eder , H. , Jagsch , R. , Peternell , A. , Stuhlinger , G. and Kasper , S. 1999 . Buprenorphine versus methadone maintenance for the treatment of opioid dependence . Addiction , 94 ( 9 ) : 1337 – 1347 . doi: 10.1046/j.1360-0443.1999.94913376.x
  • Gerra , G. , Leonardi , C. , D’Amore , A. , Strepparola , G. , Fagetti , R. , Assi , C. and Lucchini , A. 2006 . Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study . Progress in Neuro-Psychopharmacology & Biological Psychiatry , 30 ( 2 ) : 265 – 272 . doi: 10.1016/j.pnpbp.2005.10.007
  • Goel , N. and Bale , T. L. 2009 . Examining the intersection of sex and stress in modelling neuropsychiatric disorders . Journal of Neuroendocrinology , 21 ( 4 ) : 415 – 420 . doi: 10.1111/j.1365-2826.2009.01843.x
  • Gold , M. S. , Donabedian , R. K. , Dillard , M. Jr , Slobetz , F. W. , Riordan , C. E. and Kleber , H. D. 1977 . Antipsychotic effect of opiate agonists . Lancet , 2 ( 8034 ) : 398 – 399 .
  • Gold , M. S. , Redmond , D. E. Jr , Donabedian , R. K. , Goodwin , F. K. and Extein , I. 1978 . Increase in serum prolactin by exogenous and endogenous opiates: Evidence for antidopamine and antipsychotic effects . The American Journal of Psychiatry , 135 ( 11 ) : 1415 – 1416 .
  • Grant , B. F. 1996 . Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the national longitudinal alcohol epidemiologic survey . Journal of Substance Abuse , 8 ( 2 ) : 195 – 210 .
  • Green , A. I. 2006 . Treatment of schizophrenia and comorbid substance abuse: Pharmacologic approaches . The Journal of Clinical Psychiatry , 67 ( Suppl. 7 ) : 31–35; quiz 36–37
  • Healy , D. J. and Meador-Woodruff , J. H. 1994 . Prodynorphin-derived peptide expression in primate cortex and striatum . Neuropeptides , 27 ( 5 ) : 277 – 284 .
  • Judd , L. L. and Janowsky , D. S. 1981 . Effects of narcotics and narcotic antagonists on affective disorders, schizophrenia and serum neurohormones . Modern Problems of Pharmacopsychiatry , 17 : 213 – 225 .
  • Kleber , H. D. and Gold , M. S. 1978 . Use of psychotropic drugs in treatment of methadone maintained narcotic addicts . Annals of the New York Academy of Sciences , 311 : 81 – 98 .
  • Koob , G. F. and Le Moal , M. 2008 . Review. neurobiological mechanisms for opponent motivational processes in addiction . Philosophical Transactions of the Royal Society of London Series B, Biological Sciences , 363 ( 1507 ) : 3113 – 3123 . doi: 10.1098/rstb.2008.0094
  • Le Merrer , J. , Becker , J. A. , Befort , K. and Kieffer , B. L. 2009 . Reward processing by the opioid system in the brain . Physiological Reviews , 89 ( 4 ) : 1379 – 1412 . doi: 10.1152/physrev.00005.2009
  • Manchikanti , L. , Fellows , B. , Ailinani , H. and Pampati , V. 2010 . Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective . Pain Physician , 13 ( 5 ) : 401 – 435 .
  • Margolese , H. C. , Malchy , L. , Negrete , J. C. , Tempier , R. and Gill , K. 2004 . Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences . Schizophrenia Research , 67 ( 2–3 ) : 157 – 166 . doi: 10.1016/S0920-9964(02)00523-6
  • McKenna , G. J. 1982 . Methadone and opiate drugs: Psychotropic effect and self-medication . Annals of the New York Academy of Sciences , 398 : 44 – 55 .
  • Mueser , K. T. , Bellack , A. S. and Blanchard , J. J. 1992 . Comorbidity of schizophrenia and substance abuse: Implications for treatment . Journal of Consulting & Clinical Psychology , 60 ( 6 ) : 845 – 856 .
  • Nestler , E. J. and Carlezon , W. A. Jr. 2006 . The mesolimbic dopamine reward circuit in depression . Biological Psychiatry , 59 ( 12 ) : 1151 – 1159 . doi: 10.1016/j.biopsych.2005.09.018
  • Nyswander , M. E. 1956 . The drug addict as a patient. , New York , NY : Grune & Stratton .
  • Nylander , I. , Vlaskovska , M. and Terenius , L. 1995 . Brain dynorphin and enkephalin systems in Fischer and Lewis rats: Effects of morphine tolerance and withdrawal . Brain Research , 683 ( 1 ) : 25 – 35 .
  • Office of National Drug Control Policy, US Executive Office of the President . 2011 . Epidemic: Responding to America's prescription drug abuse crisis. , Washington , DC : Author . Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf
  • Ramsdell , C. D. and Meador-Woodruff , J. H. 1993 . Expression of prodynorphin-derived peptides and mRNA in guinea-pig cortex . Neuropeptides , 25 ( 2 ) : 131 – 138 .
  • Regier , D. A. , Farmer , M. E. , Rae , D. S. , Locke , B. Z. , Keith , S. J. , Judd , L. L. and Goodwin , F. K. 1990 . Comorbidity of mental disorders with alcohol and other drug abuse results from the epidemiologic catchment area (ECA) study . JAMA: The Journal of the American Medical Association , 264 ( 19 ) : 2511 – 2518 .
  • Schmidt , L. M. , Hesse , M. and Lykke , J. 2011 . The impact of substance use disorders on the course of schizophrenia–a 15-year follow-up study: Dual diagnosis over 15 years . Schizophrenia Research , 130 ( 1–3 ) : 228 – 233 . doi: 10.1016/j.schres.2011.04.011
  • Smelson , D. A. , Dixon , L. , Craig , T. , Remolina , S. , Batki , S. L. , Niv , N. and Owen , R. 2008 . Pharmacological treatment of schizophrenia and co-occurring substance use disorders . CNS Drugs , 22 ( 11 ) : 903 – 916 .
  • Substance Abuse and Mental Health Services Administration . 2012 . Results from the 2011 National Survey on Drug Use and Health: Summary of national findings. , Rockville , MD : Author . NSDUH Series H-44, HHS Publication No. (SMA) 12–4713. Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/nsduhresults2011.pdf
  • Sullivan , M. D. , Edlund , M. J. , Zhang , L. , Unutzer , J. and Wells , K. B. 2006 . Association between mental health disorders, problem drug use, and regular prescription opioid use . Archives of Internal Medicine , 166 ( 19 ) : 2087 – 2093 . doi: 10.1001/archinte.166.19.2087
  • Tamminga , C. A. and Holcomb , H. H. 2005 . Phenotype of schizophrenia: A review and formulation . Molecular Psychiatry , 10 ( 1 ) : 27 – 39 . doi: 10.1038/sj.mp.4001563
  • Tejeda , H. A. , Shippenberg , T. S. and Henriksson , R. 2012 . The dynorphin/kappa-opioid receptor system and its role in psychiatric disorders . Cellular and Molecular Life Sciences: CMLS , 69 ( 6 ) : 857 – 896 . doi: 10.1007/s00018-011-0844-x
  • Unglaub , W. , Kandel , M. , Zenner , D. , Wodarz , N. and Klein , H. 2003 . Neuroleptic treatment of opiate addicts with a comorbid schizophrenia in a methadone maintenance program . Psychiatrische Praxis, , 30 ( Suppl. 2 ) : 121 – 124 . [Neuroleptikatherapie von komorbiden Opiatabhangigen in der Methadonambulanz]; doi:10.1055/s-2003-39754
  • Verebey , K. , Volavka , J. and Clouet , D. 1978 . Endorphins in psychiatry: An overview and a hypothesis . Archives of General Psychiatry , 35 ( 7 ) : 877 – 888 .
  • Warner , M. , Chen , L. H. , Makuc , D. M. , Anderson , R. N. and Miniño , A. M. 2011 . “ Drug poisoning deaths in the United States, 1980–2008 ” . In NCHS Data Brief, No. 81. , Hyattsville , MD : National Center for Health Statistics . Retrieved from http://www.cdc.gov/nchs/data/databriefs/db81.htm
  • Weber , E. , Evans , C. J. and Barchas , J. D. 1982 . Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions . Nature , 299 ( 5878 ) : 77 – 79 .
  • Wellisch , D. K. , Gay , G. R. , Wesson , D. R. and Smith , D. E. 1971 . The psychotic heroin addict . Journal of Psychoactive Drugs , 4 ( 1 ) : 46 – 49 . doi: 10.1080/02791072.1971.10471785
  • Wikler , A. and Rasor , R. W. 1953 . Psychiatric aspects of drug addiction . The American Journal of Medicine , 14 ( 5 ) : 566 – 570 .
  • Wu , L. T. , Woody , G. E. , Yang , C. and Blazer , D. G. 2011 . How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions . Journal of Addiction Medicine , 5 ( 1 ) : 28 – 35 . doi: 10.1097/ADM.0b013e3181e0364e
  • Ziedonis , D. M. , Smelson , D. , Rosenthal , R. N. , Batki , S. L. , Green , A. I. , Henry , R. J. and Weiss , R. D. 2005 . Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations . Journal of Psychiatric Practice , 11 ( 5 ) : 315 – 339 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.